BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28258561)

  • 1. A resected case of two branch duct-type intraductal papillary mucinous neoplasms showing different clinical courses after a two-year follow-up.
    Shibata H; Ohike N; Norose T; Isobe T; Suzuki R; Imai H; Shiokawa A; Takimoto M; Tabuchi A; Takano Y; Yamamura E; Nagahama M; Takeyama N; Yokomizo K; Mizukami H; Tanaka JI; Aoki T; Murakami M
    Clin J Gastroenterol; 2017 Jun; 10(3):274-278. PubMed ID: 28258561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A rare case of intraductal tumor of the pancreas in which an intraductal tubulopapillary neoplasm was mixed with a widely spreading gastric-type intraductal papillary-mucinous neoplasm].
    Wakabayashi T; Shirota Y; Takeda Y; Hodo Y; Ueda Y
    Nihon Shokakibyo Gakkai Zasshi; 2024; 121(5):415-424. PubMed ID: 38735750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT findings and clinical effects of high grade pancreatic intraepithelial neoplasia in patients with intraductal papillary mucinous neoplasms.
    Kim MC; Kim JH; Jeon SK; Kang HJ
    PLoS One; 2024; 19(4):e0298278. PubMed ID: 38683769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abdominal ultrasound in the characterization of branch-duct intraductal papillary mucinous neoplasms: A new tool for surveillance of low-risk patients?
    Ferronato M; Lizzio CE; Berardinelli D; Marini D; Elia E; Andreetto L; Trentini A; Potenza MC; Serra C; Mazzotta E; Ricci C; Casadei R; Migliori M
    Dig Liver Dis; 2024 Jun; 56(6):1071-1077. PubMed ID: 38042636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of high-risk stigmata and worrisome features with advanced neoplasia in intraductal papillary mucinous neoplasms (IPMN): A systematic review.
    Ohno E; Balduzzi A; Hijioka S; De Pastena M; Marchegiani G; Kato H; Takenaka M; Haba S; Salvia R
    Pancreatology; 2024 Feb; 24(1):48-61. PubMed ID: 38161091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic Ductal Adenocarcinoma Concomitant with Main Duct Type Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Case Report.
    Yonamine K; Koshita S; Kanno Y; Ogawa T; Kusunose H; Sakai T; Miyamoto K; Kozakai F; Okano H; Okada T; Oikawa M; Tsuchiya T; Sawai T; Noda Y; Ito K
    Am J Case Rep; 2021 Sep; 22():e932565. PubMed ID: 34473678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term surveillance of branch-duct intraductal papillary mucinous neoplasms without worrisome or high-risk features.
    Lattimore CM; Kane WJ; Subbarao S; Venitti C; Cramer CL; Turkheimer LM; Bauer TW; Turrentine FE; Zaydfudim VM
    J Surg Oncol; 2023 Dec; 128(7):1087-1094. PubMed ID: 37530526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal Surveillance Interval of Branch Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas.
    Han Y; Kwon W; Lee M; Jung HS; Yun WG; Cho YJ; Chae YS; Fernández-Del Castillo C; Marchegiani G; Salvia R; Goh BKP; Lee WJ; Jang JY
    JAMA Surg; 2024 Apr; 159(4):389-396. PubMed ID: 38231494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoepithelial cyst of the pancreas: can common imaging features help to avoid resection?
    Khristenko E; Garcia EE; Gaida MM; Hackert T; Mayer P; Kauczor HU; Klauss M
    Langenbecks Arch Surg; 2023 Feb; 408(1):82. PubMed ID: 36773118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is preoperative pancreatic juice cytology useful for determining therapeutic strategies for patients with intraductal papillary mucinous neoplasm of the pancreas?
    Nagayama R; Ueki T; Shimizu Y; Hijioka S; Nakamura M; Kitano M; Hara K; Masamune A; Kin T; Hanada K; Koshita S; Yamada R; Takenaka M; Itoi T; Yanagisawa A; Otuka T; Hirono S; Kanno A; Ideno N; Kuwahara T; Shimizu A; Kamata K; Asai Y; Takeyama Y
    J Hepatobiliary Pancreat Sci; 2024 Mar; 31(3):183-192. PubMed ID: 38084510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison with surgically resected mucinous cystic neoplasm of pancreas and branch-duct type intraductal papillary mucinous neoplasm considering clinico-radiological high-risk features: a reassessment of current guidelines.
    Kim H; Kim JH; An J; Choi JS
    Abdom Radiol (NY); 2024 May; ():. PubMed ID: 38744705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic medullary carcinoma developed on a pancreatic intraductal papillary mucinous neoplasm with loss of MSH2 and MSH6 expression: a case report.
    Verocq C; Racu ML; Bafort D; Butorano G; Perez-Casanova Garcia L; Navez J; Witterwulghe M; Sheahan K; Swan N; Closset J; Van Laethem JL; Maris C; D'Haene N
    Diagn Pathol; 2021 Dec; 16(1):117. PubMed ID: 34895278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging-derived fat fraction predicts risk of malignancy in intraductal papillary mucinous neoplasm.
    Evrimler S; Yip-Schneider MT; Swensson J; Soufi M; Muraru R; Tirkes T; Schmidt CM; Akisik F
    Abdom Radiol (NY); 2021 Oct; 46(10):4779-4786. PubMed ID: 34086091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic value of abbreviated MRI protocol in the surveillance of Branch-Duct intraductal papillary mucinous neoplasm.
    Malekzadeh S; Cannella R; Fournier I; Hiroz P; Mottet C; Constantin C; Widmer L
    Eur J Radiol; 2024 Jun; 175():111455. PubMed ID: 38608499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review on surveillance for non-resected branch-duct intraductal papillary mucinous neoplasms of the pancreas.
    Kazmi SZ; Jung HS; Han Y; Yun WG; Cho YJ; Lee M; Kwon W; Castillo CF; Del Chiaro M; Marchegiani G; Goh BKP; Hijioka S; Majumder S; Nakai Y; Shin A; Jang JY
    Pancreatology; 2024 May; 24(3):463-488. PubMed ID: 38480047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Outcomes and Risk of Pancreatic Cancer in Intraductal Papillary Mucinous Neoplasms.
    de la Fuente J; Chatterjee A; Lui J; Nehra AK; Bell MG; Lennon RJ; Kassmeyer BA; Graham RP; Nagayama H; Schulte PJ; Doering KA; Delgado AM; Vege SS; Chari ST; Takahashi N; Majumder S
    JAMA Netw Open; 2023 Oct; 6(10):e2337799. PubMed ID: 37847503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance for Presumed BD-IPMN of the Pancreas: Stability, Size, and Age Identify Targets for Discontinuation.
    Marchegiani G; Pollini T; Burelli A; Han Y; Jung HS; Kwon W; Rocha Castellanos DM; Crippa S; Belfiori G; Arcidiacono PG; Capurso G; Apadula L; Zaccari P; Noia JL; Gorris M; Busch O; Ponweera A; Mann K; Demir IE; Phillip V; Ahmad N; Hackert T; Heckler M; Lennon AM; Afghani E; Vallicella D; Dall'Olio T; Nepi A; Vollmer CM; Friess H; Ghaneh P; Besselink M; Falconi M; Bassi C; Goh BK; Jang JY; Fernández-Del Castillo C; Salvia R
    Gastroenterology; 2023 Oct; 165(4):1016-1024.e5. PubMed ID: 37406887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum elastase-1 predicts malignancy in intraductal papillary mucinous neoplasm of the pancreas.
    Mishima T; Takano S; Takayashiki T; Kuboki S; Suzuki D; Sakai N; Hosokawa I; Konishi T; Nishino H; Nakada S; Kouchi Y; Kishimoto T; Ohtsuka M
    Pancreatology; 2024 Feb; 24(1):93-99. PubMed ID: 38102054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatobiliary fistula associated with intraductal papillary mucinous carcinoma accompanying obstructive jaundice: A case report.
    Komo T; Oishi K; Kohashi T; Hihara J; Kanou M; Nakashima A; Kaneko M; Mukaida H; Hirabayashi N
    Int J Surg Case Rep; 2018; 48():126-130. PubMed ID: 29890488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of age, comorbidities and relevant changes on surveillance strategy of intraductal papillary mucinous neoplasms: a competing risk analysis.
    Crippa S; Marchegiani G; Belfiori G; Rancoita PVM; Pollini T; Burelli A; Apadula L; Scarale MG; Socci D; Biancotto M; Vanella G; Arcidiacono PG; Capurso G; Salvia R; Falconi M
    Gut; 2024 Apr; ():. PubMed ID: 38653539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.